- Category
- Science
- Published
- Friday, July 17, 2026 at 4:19 AM
- Publisher
-
ScienceDaily
How does this news make you feel?
New Alzheimer's drug repairs DNA damage and reduces brain inflammation
Quick Summary
A drug originally developed for spinal cord injury may offer a fresh approach to treating Alzheimer’s disease. In mouse studies, KCL-286 repaired dangerous DNA damage, reduced inflammation, and targeted multiple disease-related pathways instead of focusing on just amyloid or tau. Since it has already cleared an initial human safety trial, researchers believe it could move more quickly into Alzheimer’s clinical testing.
Comments (0)
Join the conversation. Comments are rate-limited, secured, and GDPR-compliant.
No comments yet. Be the first to share your thoughts!